Division of Radiation Oncology, Department of Radiology, University of the Philippines, Philippine General Hospital, Manila, the Philippines.
College of Medicine, University of the Philippines, Manila, the Philippines; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
J Cancer Policy. 2024 Sep;41:100485. doi: 10.1016/j.jcpo.2024.100485. Epub 2024 May 18.
Cancer is the third leading cause of death in the Philippines. Radiotherapy (RT) is integral to the treatment and palliation of cancer. Therefore, RT resources across the country must be surveyed and optimized.
Online surveys were sent to the heads of all 50 RT facilities in the Philippines. The survey included items regarding the facility itself, personnel, and available services.
The survey had a 98% response rate. 76% of RT facilities in the Philippines are privately owned; 12 are government/public institutions and 8 are academic centers. Over a third are in the National Capital Region; three regions are without a single RT facility. For a population of >110 million, the Philippines has 53 linear accelerators, 125 radiation oncologists, 56 residents, 114 medical physicists, 113 radiation oncology nurses, and 343 radiation therapists. Nine radiation oncology residency programs are active. All facilities are capable of 3D conformal radiotherapy, and 96% are capable of intensity modulated radiotherapy. <30% offer stereotactic radiotherapy, and <50% offer HDR brachytherapy.
While there has been significant expansion of RT resources over the years, RT remains inaccessible for many in the Philippines. Urgent investment in training and retaining RT personnel is needed as well. Policy summary: With its current cancer burden, the Philippines needs at least 170 linear accelerators, 300 radiation oncologists, and 150 medical physicists. Public/government cancer centers must be built, with priority given to regions without RT facilities. HDR brachytherapy and stereotactic radiotherapy services must also be expanded. A national RT task force must be created to ensure the quality, availability, and accessibility of RT in the Philippines. Further work exploring payment schemes that improve access to RT and mitigate financial toxicity is needed, as well as integration of radiation oncology providers and health policy experts into national health system decision making.
癌症是菲律宾的第三大死因。放射治疗(RT)是癌症治疗和缓解的重要组成部分。因此,必须对全国的 RT 资源进行调查和优化。
向菲律宾所有 50 个 RT 设施的负责人发送在线调查。调查包括有关设施本身、人员和可用服务的项目。
调查的回复率为 98%。菲律宾的 76%的 RT 设施为私营所有;12 个为政府/公共机构,8 个为学术中心。超过三分之一的设施位于首都地区;三个地区没有一个 RT 设施。对于超过 1.1 亿人口的菲律宾,拥有 53 台线性加速器、125 名肿瘤放射科医生、56 名住院医师、114 名医学物理学家、113 名肿瘤放疗护士和 343 名放射治疗师。有 9 个肿瘤放疗住院医师培训计划正在运行。所有设施都有能力进行 3D 适形放疗,96%的设施都有能力进行调强放疗。不到 30%的设施提供立体定向放疗,不到 50%的设施提供 HDR 近距离放疗。
尽管近年来 RT 资源有了显著扩展,但菲律宾仍有许多人无法获得 RT。还需要迫切投资培训和留住 RT 人员。政策摘要:根据菲律宾目前的癌症负担,菲律宾至少需要 170 台线性加速器、300 名肿瘤放射科医生和 150 名医学物理学家。必须建立公共/政府癌症中心,并优先考虑没有 RT 设施的地区。还必须扩大 HDR 近距离放疗和立体定向放疗服务。必须创建一个国家 RT 工作组,以确保菲律宾 RT 的质量、可用性和可及性。还需要进一步探索改善 RT 可及性和减轻财务毒性的支付方案,并将肿瘤放疗提供者和卫生政策专家纳入国家卫生系统决策。